Reactions Weekly

July 2018, Volume 1710, Issue 1, pp 12–12 | Cite as

Ustekinumab safe but may reactivate hepatitis B

Clinical study

First Online: 14 July 2018

• 21 Downloads

This is a preview of subscription content, log in to check access.

Reference

1. Ting SW, et al. Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab. Clinical Drug Investigation : 2 Jul 2018. Available from: URL: http://doi.org/10.1007/s40261-018-0671-z

Copyright information

© Springer Nature Switzerland AG 2018